The Impact of Tobacco Use on COVID-19 Outcomes: A Systematic Review.
| Autor: | Baker, Jessica, Krishnan, Nandita, Abroms, Lorien C., Berg, Carla J. |
|---|---|
| Předmět: |
ADVERSE health care events
ONLINE information services STATISTICS REVERSE transcriptase polymerase chain reaction PNEUMONIA DISEASE progression COVID-19 SAMPLE size (Statistics) MANUSCRIPTS SYSTEMATIC reviews MULTIVARIATE analysis PATIENTS BEHAVIOR RISK assessment HOSPITAL admission & discharge ARTIFICIAL respiration SEVERITY of illness index SOCIOECONOMIC factors COMPARATIVE studies DESCRIPTIVE statistics HOSPITAL care TOBACCO products MEDLINE THEMATIC analysis POLYMERASE chain reaction VIRAL antibodies COMPUTED tomography SMOKING HYPOXEMIA |
| Zdroj: | Journal of Smoking Cessation; 1/20/2022, p1-11, 11p |
| Abstrakt: | Introduction. Tobacco use increases risks for numerous diseases, including respiratory illnesses. We examined the literature to determine whether a history of tobacco use increases risks for adverse outcomes among COVID-19 patients. Methods. We conducted a systematic search of PubMed, LitCovid, Scopus, and Europe PMC (for preprints) using COVID-19 and tobacco-related terms. We included studies of human subjects with lab-confirmed COVID-19 infections that examined tobacco use history as an exposure and used multivariable analyses. The data was collected between March 31st, 2020, and February 20th, 2021. Outcomes included mortality, hospitalization, ICU admission, mechanical ventilation, and illness severity. Results. Among the 39 studies (33 peer-reviewed, 6 preprints) included, the most common outcome assessed was mortality (n = 32). The majority of these studies (17/32) found that tobacco use increased risk, one found decreased risk, and 14 found no association. Tobacco use was associated with increased risk of hospitalization in 7 of 10 studies, ICU admission in 6 of 9 studies, mechanical ventilation in 2 of 6 studies, and illness severity in 3 of 9 studies. One study found that tobacco use history increased risk of pulmonary embolism in COVID-19 patients. Tobacco use was found to compound risks associated with diabetes (n = 1), cancer (n = 2), and chronic liver disease (n = 1). Conclusion. There is strong evidence that tobacco use increases risks of mortality and disease severity/progression among COVID-19 patients. Public health efforts during the pandemic should encourage tobacco users to quit use and seek care early and promote vaccination and other preventive behaviors among those with a history of tobacco use. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|